FinDogFinDog
Friday, October 30, 2026Closing data · 4:00 PM ET
English
Log in

CAH

Cardinal HealthNYSE · Health Care Distributors · Health Care
Previous close
250.48
Change
−0.61 / −0.24%
FinDog View
Bullish
52-Week Range ?
180.45 – 259.84
P/E (TTM) ?
34.2
Forward P/E ?
17.3
Based on consensus earnings for the next 12 months
Market Cap
$58.8B
1M
+12.58%
S&P 500 −0.91% over same period
Volume / Avg Volume
1.9M / 1.8M
1.05× average
Latest earnings analysisFY2026 Q4Reported 2026-08-11

Cardinal Health FY2026: revenue up 14% to $254.2 billion, EPS lifted by refund

Cardinal Health finished fiscal 2026 with $254.2 billion of revenue, up 14%, and GAAP diluted EPS of $7.23 against $11.26 on a non-GAAP basis. That $4.03 gap is the story: a $100 million tariff refund and a long list of excluded charges separate the two numbers. Think of it as a distributor earning pennies on every dollar of sales — good execution, noisy optics.

Read the full analysis →
Revenue$254.25BYoY +322.60%
EPS (non-GAAP)$2.91Beatest. $2.44
Next-day move−2.54%

Price History

Closing price · USD1M6M1Y5Y
0100200300EEEEEE2021-102023-012024-042025-082026-10

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 39.01M6M1Y5Y
30354045502025-102026-012026-052026-082026-10

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis

Next Earnings

Date and consensus from the earnings calendar; the analysis is generated automatically after the releaseEarnings Calendar →
Report date
2026-11-05
in 4 days · Pre-market
Consensus EPS
$2.97
Last quarter EPS $2.91
Avg. next-day move over the last 6 reports
±1.4%

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 38 of its 5-year rangeMid-range
5-year range 23.9 – 122.4 · Median 37.9
Last 4 quarters: $758M in buybacks + $371M in dividends, 1.92% of market cap combined
P/E (TTM)
34.2
P/B
58.8
P/S
0.2
Dividend Yield
1.88%
Earnings Reaction
Over the last 6 reports, the stock moved ±1.4% on average on the first trading day after, rising 4 times
Most recent −2.54%
Volatility & Correlation
1-year beta -0.12 · Correlation with S&P 500 -0.05Low beta
Annualized volatility 30% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 8 · $59.6MNet selling $59.6M
  • 08-19Hollar Jason M.Chief Executive OfficerSell$10.5M44,529 shares · 6 trades · Avg price 236.18
  • 08-19Scherer Mary C.Chief Accounting OfficerSell$0.55M2,302 shares · 2 trades · Avg price 237.39
  • 08-18Greene Michelle D.Chief Information OfficerSell$2.7M11,650 shares · 4 trades · Avg price 235.72
  • 08-18Mayer Jessica LChief Legal/Compliance OfficerSell$7.0M29,436 shares · 4 trades · Avg price 236.19
  • 08-18Alt Aaron EChief Financial OfficerSell$9.9M42,000 shares · 4 trades · Avg price 236.34
  • 08-18WEITZMAN DEBORAHCEO, PSS SegmentSell$1.7M7,354 shares · 3 trades · Avg price 235.45
  • 08-18Mason Stephen MCEO, GMPD SegmentSell$8.3M35,000 shares · 4 trades · Avg price 236.40
  • 08-18Hollar Jason M.Chief Executive OfficerSell$18.9M80,000 shares · 4 trades · Avg price 235.74
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q464.45+7.1%4.4%0.810.56——
FY2026 Q265.63+18.8%3.7%0.710.470.56—
FY2026 Q164.01+22.4%3.6%0.670.450.871.88
FY2025 Q460.16+0.5%3.7%0.430.241.30—
FY2025 Q354.88+0.0%3.9%0.730.512.79—
FY2025 Q255.26−3.8%3.5%0.550.40-0.50—
FY2025 Q152.28−4.3%3.6%0.570.42-1.741.70
FY2024 Q459.87+12.1%3.1%0.400.241.890.93
FY2024 Q354.87+8.7%3.5%0.370.26-0.141.07
FY2024 Q257.44+11.6%3.2%0.510.371.071.50
FY2024 Q154.65+10.2%3.2%-0.03-0.010.44-0.05
FY2023 Q453.42+13.5%3.3%0.11-0.060.65-0.21

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView